Replies to post #681983 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

Nope!; ). Approval brings attention and interest that can be responded to. Approval allows patients to access set aside funds in the UK immediately. Approval allows Linda to talk about a PLATFORM treatment that initially can be considered for study and off label use in all solid tumor tumors. Approval gets investors talking about partnerships and implications regarding impact on valuations of competitors and potential partners including on companies that they are invested in already. Approval brings steadily rising interest and share price as new investors go through their own learning curves and market makers will no longer be able to control the flow of information by controlling the price as much as they have in the past. Best wishes.

Nope what? Your long blablabla word salad is a "subject" I never brought up nor did I claim the opposite. My post, you responded with your word salad nonsense to, was about the stock price development after UK approval.

Buy other reading glasses

[meirluc]

Doc, all your comments about the consequences for the SP after
approval seem very valid to me but with respect to partnership, has
not NWBO hinted at the time of MAA submission that a combo
trial(s) agreement with a BP is likely to be initiated already before
approval (when MAA has been cemented)?

When that partnership is announced, I expect the SP to be affected
in a positive way, even if that event has occurred prior to MHRA approval.